Tamiflu gets paediatric indication
Roche's oseltamivir (Tamiflu) has been given marketing approval for use in children over 12 months old with influenza. The paediatric formulation is in the form of a tutti-frutti-flavoured oral suspension.
Roche's oseltamivir (Tamiflu) has been given marketing approval for use in children over 12 months old with influenza. The paediatric formulation is in the form of a tutti-frutti-flavoured oral suspension.